• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Nektar Therapeutics

+ Add to Watchlist

ITH:GR

8.011 EUR 0.047 0.58%

As of 08:23:28 ET on 07/22/2014.

Company Profile for Nektar Therapeutics (ITH)

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.

Contact Information

Nektar Therapeutics

455 Mission Bay Blvd South
San Francisco, CA 94158
United States
Phone: 1-415-482-5300
Fax: 1-415-339-5300

Key Executives for Nektar Therapeutics (ITH)

Howard W RobinPresident/CEOJohn L NicholsonSenior VP/CFO
Stephen K DobersteinSenior VP/Chief Scientific OfcrGil M LabrucherieSenior VP/Secy/Gen Counsel
Ivan P GergelSenior VP:Drug Dev/Chief Medical OfcrJillian B ThomsenSenior VP:Finance
Maninder HoraSenior VP:Pharmaceutical Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil